Itse asiassa tarkennuksia
U.S. Calls for Pause on Johnson & Johnson Vaccine After Clotting Cases
AstraZeneca Vaccine and Blood Clots: What Is Known So Far
- Out of 34 million people who received the vaccine in Britain, the European Union and three other countries, 222 experienced blood clots that were linked with a low level of platelets.
- On Tuesday, the Australian government
announced it would not purchase Johnson & Johnson vaccines.
- AstraZeneca has not yet applied for an emergency use authorization in the United States.
- So far, researchers in Europe have not identified any underlying medical condition among the vaccine recipients who developed severe clotting issues that would help explain their susceptibility.
- Some health officials have said that younger people appear to be at slightly higher risk from the clots. Because those people are also less likely to develop severe Covid, regulators said, any vaccine being given in that age group has to clear a higher safety bar.
Eli lyhyesti, lääke on tappavampi kuin sairaus tämänhetkisen tiedon varassa nuorille. Viittaan tähän lauseseen.
"The only group for whom they said the risk of the clotting problems outstripped that of coronavirus-related intensive care admissions was people under 30 living in a place with low rates of Covid cases."
Lisäyksenä Aamulehden koronanyrkki seuranta variantteihin
Suora lähetys juuri nyt: Rajoitukset lievenevät hieman Pirkanmaalla, tapausmäärissä maltillinen lasku – Aamulehti seuraa koronanyrkin tiedotustilaisuutta
"koulussa ollut laaja altistuminen oli UK variantille, mutta kukaan ei sairastunut"
"työpaikalla ollut UK variantti sairastutti puolet altistuneista"
Lapsille UK variantti ei tunnu olevan yhtään tarttuvampi kuin vanilla, mutta aikuisille on